AI-generated summary
The authors studied oocytes from women with polycystic ovary syndrome in a laboratory (in vitro) setting, comparing control, extracellular vesicle (ECV) and photobiomodulation therapy (PBMT) groups. They report higher rates of mature oocytes and changes in apoptosis, autophagy and oxidative stress markers in the ECV and PBMT groups. The study was conducted in vitro, so these findings do not directly show effects in women.
- Who or what was studied
- Oocytes obtained after ovarian stimulation from women with polycystic ovary syndrome referred for infertility treatment
- Limits stated in the abstract
- The study was in vitro, so the results do not directly show clinical effects in women.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Reactive oxygen species. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.